CVE-2026-61400: high-severity vulnerability in Apache CloudStack
Apache CloudStack: Get and Run Diagnostics Command Injection
Published · Updated
E-mail alert when it lands in KEV, gets a public PoC or its score goes up.
21Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 8.8epss 2.9%
Improper Neutralization of Special Elements used in a Command ('Command Injection') vulnerability in Apache CloudStack's run and get diagnostics functionality for the system VMs and virtual routers.
An authenticated user holding the permissions required to invoke either `getDiagnosticsData` or `runDiagnostics` can achieve arbitrary command execution on the system VM and/or Virtual Router instances, with commands running as root (or as the diagnostics-process user, at minimum). This represents a full compromise of the affected instance and, depending on network segmentation, may provide a foothold for lateral movement within the CloudStack-managed infrastructure, including access to guest network traffic handled by the compromised Virtual Router.
The getDiagnosticsData and runDiagnostics APIs are restricted to only Admin role accounts by default.
This issue affects Apache CloudStack: from 4.20.0.0 through 4.20.3.0 and from 4.21.0.0 through 4.22.1.0.
Users are recommended to upgrade to version 4.20.3.1 or 4.22.1.1 or later, which fixes the issue.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Affected products
Apache Software Foundation · Apache CloudStackRelated CVEs — Apache CloudStack
In the same product, most dangerous first.
CVE-2024-41107HIGHApache CloudStack: SAML Signature ExclusionEPSS 17.8%CVE-2022-35741—Apache CloudStack SAML Single Sign-On XXEEPSS 8.0%CVE-2016-6813—CVE-2016-6813EPSS 5.6%CVE-2024-38346CRITICALApache CloudStack: Unauthenticated cluster service port leads to remote executionEPSS 3.3%CVE-2022-26779—Apache Cloudstack insecure random number generation affects project email invitationEPSS 2.9%CVE-2025-22828MEDIUMApache CloudStack: Unauthorised access to annotationsEPSS 2.1%